Certara, Inc. Stock News

PRINCETON, N.J.--(BUSINESS WIRE)--Certara announced the closing of its underwritten public offering of its common stock at a public offering price of $25.00 per share.

PRINCETON, N.J.--(BUSINESS WIRE)--Certara announced the pricing of its public offering of common stock by certain existing stockholders at a price of $25.00 per share.

PRINCETON, N.J.--(BUSINESS WIRE)--Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it is set to join the Russell 1000® Index.

Certara, Inc. (CERT) CEO William Feehery on Q4 2020 Results - Earnings Call Transcript

PRINCETON, N.J.--(BUSINESS WIRE)--Certara, a global leader in biosimulation, today reported its preliminary results for the fourth quarter and full year ending December 31, 2020.

PRINCETON, N.J.--(BUSINESS WIRE)--Certara today announced that William Feehery, CEO and Andrew Schemick, CFO will virtually present at the Barclays Global Healthcare Conference.

PRINCETON, N.J.--(BUSINESS WIRE)--2020 was the 7th consecutive year where 90% of new drug & biologic approvals by the FDA were received by Certara's customers.

STOCKHOLM, Dec. 17, 2020 /PRNewswire/ -- EQT is pleased to announce that on 10 December 2020, the EQT VII portfolio company Certara, Inc. ("Certara"), a global leader in biosimulation based on 2019 re

Hot initial public offerings aren't just for technology companies.

Dec.11 -- Certara Inc., a maker of drug-development software, upsized its initial public offering and priced it above the marketed range to raise $668 million, adding to the red-hot week for U.S. list

CNBC's "Squawk Alley" team discusses Certara's IPO with CEO William Feehery.

Four companies increased the size of their deals.

PRINCETON, N.J.--(BUSINESS WIRE)--Certara today announced the pricing of its upsized initial public offering of 29,055,000 shares of its common stock at $23.00 per share.

The list of upcoming IPOs is starting to perk up. Here's a look at some interesting deals, including a variety of tech operators.